Loading...
Nandrolone Decanoate 50 Mg/1ml
A high-potency anabolic steroid injection formulated for the management of chronic wasting diseases and the treatment of specific types of refractory anemia. Stedec 50 contains Nandrolone Decanoate 50mg, a long-acting 19-nortestosterone derivative designed to promote positive nitrogen balance and enhance tissue repair.
A high-potency anabolic steroid injection formulated for the management of chronic wasting diseases and the treatment of specific types of refractory anemia. Stedec 50 contains Nandrolone Decanoate 50mg, a long-acting 19-nortestosterone derivative designed to promote positive nitrogen balance and enhance tissue repair.
Nandrolone Decanoate 50mg works by significantly increasing the rate of protein synthesis within the muscle cells. By promoting a positive nitrogen balance, it helps the body retain more protein, which is essential for the repair and growth of lean tissue.
The formulation stimulates the production of erythropoietin in the kidneys and acts directly on the bone marrow to increase the production of red blood cells. This makes it a critical therapeutic tool for managing anemias caused by renal failure or bone marrow suppression.
Nandrolone is known for its ability to improve collagen synthesis and increase bone mineral content. In clinical settings, it is often used to alleviate joint pain and improve mobility in patients suffering from degenerative bone conditions like osteoporosis.
As a decanoate ester, the active hormone is released slowly from the intramuscular injection site into the bloodstream. This provides a steady therapeutic effect for up to three weeks, reducing the frequency of administration compared to short-acting agents.
Stedec 50 is highly effective in reversing tissue breakdown in patients suffering from chronic debilitating illnesses, severe trauma, or major surgery. It helps restore physical strength and prevents further muscle wasting during prolonged recovery periods.
Compared to testosterone, Nandrolone exhibits a higher ratio of anabolic-to-androgenic activity. This allow for significant tissue-building benefits with a relatively lower risk of androgenic side effects when administered at recommended clinical doses.
Indication Management of Anemia of Renal Insufficiency, Post-Menopausal Osteoporosis, Chronic Debilitating Diseases, Catabolic States associated with Major Surgery or Trauma, Palliative Management of Breast Cancer.
Product descriptions, dosage forms, and compositions listed on the website are for reference by licensed practitioners and distributors only.
